Association between cyclin-dependent kinase 4/6 inhibitors and nephrotoxicity in patients with breast cancer: A Systematic Review and meta-analysis

Summary: Nephrotoxic adverse events (AEs) have been observed in patients with breast cancer receiving cyclin-dependent kinase (CDK) 4/6 inhibitors. This study aimed to evaluate the risk of nephrotoxicity associated with these inhibitors through a meta-analysis of 17 randomized controlled trials invo...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiayong Cui, Jinquan Sun, Xueying Zhou, Yi Li, Jiuda Zhao, Guoshuang Shen
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224025951
Tags: Add Tag
No Tags, Be the first to tag this record!